fusion inhibitor peptideAntiviral Peptides
Enfuvirtide (Fuzeon) T-20
A 36-amino acid synthetic peptide that blocks HIV-1 fusion with host cell membranes. The first FDA-approved fusion inhibitor. Binds gp41 heptad repeat region to prevent conformational changes required for viral entry. Used in treatment-experienced patients.
anti-HIVfusion-inhibitorgp41-bindingFDA-approved
3D Structure
3D Structure
4492.1 Da
Molecular Weight4,492.1 Da
Lab Tested
No
Harmful Ingredients
0
Contaminants
None
Tested Purity
--
Batch Consistency
No batch data
Mass Spec Profile
No mass spec data
Batch Info
Latest Batch—
Total Tests0
Unique Vendors0
Vendor Comparison
No vendor data yet
Analysis Summary
Purity Standard
No purity dataLab Reports
0 reports on file
Summary
A 36-amino acid synthetic peptide that blocks HIV-1 fusion with host cell membranes. The first FDA-approved fusion inhibitor. Binds gp41 heptad repeat region to prevent conformational changes required…